Treg Control of CD80/CD86 Expression Mediates Immune System Homeostasis
European Journal of Immunology · 2025
DOI: 10.1002/eji.202551771 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Yong-Hee Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cellular Immunology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Healt…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, B7-2 Antigen, B7-1 Antigen, Homeostasis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Institute of Allergy and Infectious Diseases, Division of Intramural Research.
Abstract (Originalsprache)
Foxp3 + regulatory T cells (Treg) are critical for the maintenance of self‐tolerance, and their absence or dysfunction can result in autoimmunity. To determine the critical cell type controlled by Treg and potentially the suppressor mechanism utilized by Treg in the steady state, we utilized mice expressing the diphtheria toxin receptor (DTR) exclusively on Treg cells. Complete depletion of Treg was achieved 24 h after DT treatment, but profound activation of CD4 + and CD8 + T cells as measured by induction of CD44 expression and proliferation required 3–4 days. Increased expression of CD80/CD86 was observed on dendritic cells and more prominently on macrophages after 3 days. Depletion of CD4 + T cells or macrophages resulted in ∼50% inhibition of T‐cell activation. The initial steps in T‐cell activation were completely independent of IFN‐γ or IL‐2, while upregulation of CD80/CD86 was partially dependent on IFN‐γ. Complete reversal of immune activation post‐Treg depletion was only achieved by blockade of CD80/CD86 interactions with CD28. We conclude that the major mechanism used by Treg in the steady state is the regulation of CD80/CD86 expression and dysregulation of this suppressor pathway results in lethal autoimmunity driven by co‐stimulatory signals in concert with TCR stimulation, or even by costimulatory signals alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cellular Immunology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Förderung
- NHLBI NIH HHS
- National Institute of Allergy and Infectious Diseases
- Division of Intramural Research
Zitieren
APA
Kim, Y. H., Panda, A. K., & Shevach, E. M. (2025). Treg Control of CD80/CD86 Expression Mediates Immune System Homeostasis. European Journal of Immunology. https://doi.org/10.1002/eji.202551771
Vancouver
Kim YH, Panda AK, Shevach EM. Treg Control of CD80/CD86 Expression Mediates Immune System Homeostasis. European Journal of Immunology. 2025. doi:10.1002/eji.202551771
BibTeX
@article{Kim2025,
author = {Kim, Yong-Hee and Panda, Abir K and Shevach, Ethan M},
title = {Treg Control of CD80/CD86 Expression Mediates Immune System Homeostasis},
journal = {European Journal of Immunology},
year = {2025},
doi = {10.1002/eji.202551771}
}
EUVIMED